18. Spinocerebellar degeneration Clinical trials / Disease details

Clinical trials : 71 / Drugs : 99 - (DrugBank : 30) / Drug target genes : 45 - Drug target pathways : 65

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00229632 (ClinicalTrials.gov)	September 27, 2005	29/9/2005	Idebenone to Treat Friedreich's Ataxia	A Six Month Double-Blind, Placebo-Controlled Phase 2 Clinical Trial to Determine the Safety and Effi ...	Friedreich Ataxia	Drug: Idebenone	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	9 Years	17 Years	All	51	Phase 2	United States
2	NCT00078481 (ClinicalTrials.gov)	February 2004	27/2/2004	Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia	Phase 1B Clinical Trial to Establish the Safety and Tolerability of a Multiple-Dose Regimen of Idebe ...	Friedreich Ataxia	Drug: Idebenone	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	16	Phase 1	United States
3	NCT00015808 (ClinicalTrials.gov)	May 2001	6/5/2001	Safety Study of Idebenone to Treat Friedreich's Ataxia	Phase I Clinical Trial to Establish the Maximum Tolerated Dose of Idebenonein Children, Adolescents, ...	Friedreich Ataxia	Drug: Idebenone	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	100	Phase 1	United States

First Previous1Next Last